Adherence to Clinical Practice Guidelines in the management of rare cancers remains inconsistent across Europe despite demonstrably improving patient outcomes, shows an analysis jointly conducted by ESMO and EURACAN, the European Reference Network (ERN) for rare cancers.

Two new studies published in leading scientific journals conclude that stabilizing long-term climate risks will require sustained net-negative carbon dioxide (CO₂) emissions for centuries. Approaching the problem from distinct perspectives – legal and technological feasibility on the one hand, and economic optimization under uncertainty on the other – the research converges on a consistent message: reaching net zero is not enough.